Exits
EdRIP to make 10x on Vessix sale
Edmond de Rothschild Investment Partners (EdRIP) stands to reap a sizeable 10x return on its original investment in US-based Vessix Vascular, following the $425m sale of the business to trade player Boston Scientific Corp.
NBGI Ventures sells TPV to Bausch + Lomb
NBGI Ventures has sold its portfolio company Technolas Perfect Vision (TPV) to Bausch + Lomb, which has exercised an option acquired in 2011.
Alcuin buys TileCo Group from Graphite
Alcuin Capital Partners has backed the management buyout of TileCo Group, a UK-based supplier of tile, mosaic and stone products, from Graphite Capital.
ECI sells Harmoni to CareUK
ECI Partners has made a final exit from WCI Group after selling UK-based outsourced healthcare services business Harmoni to CareUK.
DFJ Esprit exits Redkite
VC firm DFJ Esprit has exited its minority holding in UK-based financial markets surveillance specialist Redkite Financial Markets.
Incitia sell T-VIPS stake in merger with Nevion
Incitia Ventures has sold its 26% share of Norwegian video transport company T-VIPS through merging the business with Herkules Capital portfolio company Nevion.
Lion's £1.2bn partial sale of Weetabix completes
Bright Food's purchase of a 60% stake in Weetabix from Lion Capital is the largest overseas transaction ever by a Chinese company in the food and beverage sector.
Investcorp buys Georg Jensen for $140m
Investcorp has agreed to buy Danish luxury jewellery and silverware manufacturer Georg Jensen for $140m from Axcel Capital Partners.
SEP exits IndigoVision
Scottish Equity Partners (SEP) has sold its stake in Scottish video security business IndigoVision, following a number of unsuccessful MBO attempts.
Waterland buys SENIOcare from Akina
Waterland has bought Swiss long-term care group SENIOcare in an SBO from Akina.
Neo Capital exits Alain Mikli in trade sale
UK-based GP Neo Capital has sold French eyewear brand Alain Mikli International (AMI) to listed Italian trade buyer Luxottica Group.
SBOs back with a vengeance in Q3
Secondary buyouts (SBOs) climbed back to prominence in the third quarter of 2012. The number of such deals rose from 28 to 34 compared to Q2, making it the only buyout segment to record an increase in an otherwise faltering market.
Warburg's Premier Foods offloads condiments business
Premier Foods, a UK-based food products group, has sold its sweet pickle and table sauces division - including the Branston pickle brand - to the Mizkan Group for £92.5m.
Capvis and HgCapital partially exit KVT
Capvis and HgCapital have sold KVT Verbindungstechnik, a division of their Swiss portfolio company KVT Koenig Group (KVT), to trade player Bossard Group for CHF 200m.
Bridgepoint halves stake in Dorna Sports
Bridgepoint has halved its stake in Spanish sports management company Dorna Sports, according to reports.
Small deals, big results
Small deals, big results
Exponent buys HSS in SBO
Exponent Private Equity has bought UK-based tools and services supplier HSS Hire Services Group from its owners Och-Ziff and Perry Capital.
Ratos sells broadband operator Stofa for DKK 1.9bn
Ratos has agreed to sell Danish broadband and telephony operator Stofa to trade buyer SE for DKK 1.9bn (€255m) after a two-year holding period.
Equita makes 10x money on Barat Ceramics exit
Equita Management has sold its majority stake in German oxide-ceramics maker Barat Ceramics to Steadfast Capital.
Triton to exit Ruetgers
Triton has sold German chemicals business Ruetgers to Indian industrial group Rain Commodities (Rain CII) for €702m.
DBAG exits Coperion to US trade player
Deutsche Beteiligungs AG (DBAG) and its co-investment fund DBAG Fund V have sold German mechanical engineering group Coperion to US trade buyer Hillenbrand in a deal understood to be worth €400m.
IK Investment Partners agrees acquisition of Vemedia
IK Investment Partners and CEO Yvan Vindevogel have agreed to acquire a majority stake in Belgian pharmaceuticals supplier Vemedia Pharma.
Earlybird sells BMEYE for €32.5m
Earlybird has sold Dutch medical diagnostics company BMEYE to Edwards Lifescience Corporation for €32.5m, reaping a 26% IRR on its investment.
Triton in renewed sale talks for Rütgers
Triton has reportedly put dividend recapitalisation plans for German chemicals business Rütgers on hold following renewed interest from strategic buyers.